Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, B-Cell 1

Interventions

Cyclophosphamide 47 Rituximab 31 fludarabine 29 Specimen Handling 13 Magnetic Resonance Spectroscopy 13 Doxorubicin 13 pirtobrutinib 11 Vincristine 11 Prednisone 11 fludarabine phosphate 10 Immunotherapy, Adoptive 10 Etoposide 10 Bendamustine Hydrochloride 10 obinutuzumab 8 Lenalidomide 8 Biopsy 8 venetoclax 7 polatuzumab vedotin 7 glofitamab 7 zanubrutinib 6 pembrolizumab 6 Dexamethasone 6 tafasitamab 5 ibrutinib 5 etoposide phosphate 5 acalabrutinib 5 Leukapheresis 5 tazemetostat 4 loncastuximab tesirine 4 Nivolumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, B-Cell × Tubercidin × 1 year × Clear all

NCT05991388 2026-02-20

Glo-BNHL

University of Birmingham

Phase 2/3 Recruiting

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡